Insider trades
Zuga Matt, CFO of Acumen Pharmaceuticals ABOS, has filed 2 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $49.6K. The latest trade was on 01/22.
Zuga Matt
CFO & Chief Business Officer
- Company
- Acumen Pharmaceuticals ABOS
- First filing
- 23/01/03
- Trades
- 32 trades
- Buys / sales
- 2 / 11
- 12-month net buying
- −$49.6K
- Last trade
- 01/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ABOS | Open-market sale | 01/21–01/22 | 01/23 | 4,160 sh2 trades | $1.83avg. | $7,613.95 | −1.3% |
| Open-market sale | 01/08 | 01/12 | 6,888 sh | $1.82 | $12,536.16 | −3.2% | |
ABOS | Open-market sale | 01/05–01/07 | 01/07 | 14,905 sh4 trades | $1.98avg. | $29,480 | −6.4% |
ElutiaELUT | Open-market buy | 25/02/03 | 25/03/13 | 420,000 sh | $2.50 | $1,050,000 | +4.6% |
ABOS | Open-market sale10b5-1 plan | 25/01/21–25/01/23 | 25/01/23 | 33,266 sh2 trades | $1.70avg. | $56,693.84 | −12.6% |
| Open-market sale10b5-1 plan | 25/01/03 | 25/01/07 | 13,235 sh | $1.84 | $24,352.4 | −6.3% | |
| Open-market sale10b5-1 plan | 24/01/18 | 24/01/19 | 4,242 sh | $3.71 | $15,737.82 | −2.0% | |
ElutiaELUT | Open-market buy | 21/09/21 | 23/10/05 | 2,837,128 sh | In footnote | No stated value | +50.7% |
